Bridgefront Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,835
Closed -$994K 542
2025
Q4
$994K Sell
4,835
-5,197
-52% -$978K 0.25% 137
2025
Q3
$1.57M Buy
10,032
+2,824
+39% +$436K 0.46% 27
2025
Q2
$1.21M Sell
7,208
-2,976
-29% -$442K 0.32% 66
2025
Q1
$1.4M Sell
10,184
-2,016
-17% -$257K 0.41% 42
2024
Q4
$1.44M Buy
12,200
+6,496
+114% +$758K 0.49% 30
2024
Q3
$630K Sell
5,704
-4,459
-44% -$466K 0.24% 130
2024
Q2
$999K Buy
+10,163
New +$1.04M 0.42% 50
2024
Q1
Sell
-6,383
Closed -$643K 389
2023
Q4
$643K Buy
+6,383
New +$633K 0.49% 46
2023
Q2
Sell
-2,675
Closed -$202K 471
2023
Q1
$202K Sell
2,675
-6,472
-71% -$488K 0.12% 340
2022
Q4
$703K Buy
+9,147
New +$695K 0.49% 46
2021
Q4
Sell
-7,552
Closed -$374K 315
2021
Q3
$374K Buy
+7,552
New +$410K 0.39% 79
2021
Q1
Sell
-9,249
Closed -$495K 695
2020
Q4
$495K Buy
+9,249
New +$480K 0.17% 206

Other funds holding CAH

Bridgefront Capital's CAH Position: Q1 2026 in Review

Bridgefront Capital sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 4,835 shares — an estimated $994K sold.

Bridgefront Capital first reported a position in CAH in Q4 2020 and held it in 12 quarters. The position peaked at $1.57M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Bridgefront Capital reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 4,835 Cardinal Health shares in Q1 2026, an estimated $994K.
  • Bridgefront Capital first reported a position in Cardinal Health in Q4 2020 and held it in 12 quarters.
  • Bridgefront Capital's Cardinal Health position peaked at $1.57M in Q3 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.